ArticleExperimental and therapeutic medicine2020

Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR-tyrosine kinase inhibitor treatment in patients with non-small cell lung cancer from different ethnic groups.

Qiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.